Fundamental Analysis of IMV INC(NASDAQ:IMV) stock

Fundamental Rating

IMV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. Both the profitability and financial health of IMV have multiple concerns. IMV is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IMV has reported negative net income.

IMV had a negative operating cash flow in the past year.

In the past 5 years IMV always reported negative net income.

In the past 5 years IMV always reported negative operating cash flow.

1.2 Ratios

IMV has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IMV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IMV does not have a ROIC to compare to the WACC, probably because it is not profitable.

IMV has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, IMV has less shares outstanding

The debt/assets ratio for IMV is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -12.68, we must say that IMV is in the distress zone and has some risk of bankruptcy.

IMV has a worse Altman-Z score (-12.68) than 82.15% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-12.68

ROIC/WACCN/A

WACC6.97%

2.3 Liquidity

A Current Ratio of 2.93 indicates that IMV has no problem at all paying its short term obligations.

With a Current ratio value of 2.93, IMV is not doing good in the industry: 71.88% of the companies in the same industry are doing better.

IMV has a Quick Ratio of 2.93. This indicates that IMV is financially healthy and has no problem in meeting its short term obligations.

IMV has a worse Quick ratio (2.93) than 70.46% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.93
Quick Ratio	2.93

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IMV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.44%.

The Revenue has grown by 37.21% in the past year. This is a very strong growth!

IMV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.12% yearly.

EPS 1Y (TTM)4.44%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q29.29%

Revenue 1Y (TTM)37.21%

Revenue growth 3Y-8.54%

Revenue growth 5Y14.12%

Revenue growth Q2Q337.14%

3.2 Future

The Earnings Per Share is expected to grow by 15.36% on average over the next years. This is quite good.

The Revenue is expected to grow by 162.00% on average over the next years. This is a very strong growth

EPS Next Y20.34%

EPS Next 2Y22.41%

EPS Next 3Y17.34%

EPS Next 5Y15.36%

Revenue Next Year-80.66%

Revenue Next 2Y59.28%

Revenue Next 3Y71.75%

Revenue Next 5Y162%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IMV. In the last year negative earnings were reported.

Also next year IMV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

IMV's earnings are expected to grow with 17.34% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y22.41%

EPS Next 3Y17.34%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for IMV!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IMV INC

NASDAQ:IMV (4/28/2023, 7:22:14 PM)

After market: 0.8 -0.02 (-2.74%)

0.8225

-0.02 (-2.55%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap9.63M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.93
Quick Ratio	2.93
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)4.44%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y20.34%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)37.21%

Revenue growth 3Y-8.54%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

IMV INC (IMV)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens